Nectar Lifesciences Ltd. - Research Center
532649 NECLIFE Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 1,523.67 | 1,668.23 | 1,541.82 | 2,362.80 | 2,784.93 |
| Expenses | |||||
| Material consumed | 1,187.41 | 1,252.41 | 1,187.49 | 1,891.93 | 2,236.97 |
| Manufacturing expenses | 143.94 | 116.26 | 96.74 | 104.60 | 137.29 |
| Personnel expenses | 77.78 | 74.55 | 73.37 | 81.00 | 79.90 |
| Selling expenses | 0.11 | 0.11 | 0.05 | 0.07 | 0.07 |
| Adminstrative expenses | 59.72 | 66.09 | 75.02 | 67.23 | 66.81 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 1,468.95 | 1,509.42 | 1,432.67 | 2,144.83 | 2,521.03 |
| Operating profit | 54.72 | 158.81 | 109.16 | 217.97 | 263.90 |
| Other recurring income | 43.18 | 11.32 | 3.79 | 4.36 | 6.04 |
| Adjusted PBDIT | 97.90 | 170.13 | 112.95 | 222.33 | 269.94 |
| Financial expenses | 79.48 | 78.81 | 112.03 | 125.82 | 148.13 |
| Depreciation | 59.12 | 56.97 | 60.25 | 60.77 | 63.26 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | -40.69 | 34.35 | -59.34 | 35.74 | 58.55 |
| Tax charges | -18.24 | 9.03 | -11.50 | 5.68 | 11.22 |
| Adjusted PAT | -22.46 | 25.32 | -47.83 | 30.06 | 47.33 |
| Non recurring items | - | - | -25.32 | - | 0.03 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -22.46 | 25.32 | -73.15 | 30.06 | 47.36 |
| Earnigs before appropriation | 695.25 | 717.31 | 693.12 | 767.62 | 740.66 |
| Equity dividend | - | - | 1.12 | 0.89 | 1.35 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | 0.23 | - |
| Retained earnings | 695.25 | 717.31 | 691.99 | 766.49 | 739.31 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis